Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$974M |
| 2 |
JD.com
JD
|
+$620M |
| 3 |
FIGS
FIGS
|
+$559M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$447M |
| 5 |
GE Aerospace
GE
|
+$417M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$989M |
| 2 |
Microsoft
MSFT
|
+$981M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
AbCellera Biologics
ABCL
|
+$648M |
| 5 |
O'Reilly Automotive
ORLY
|
+$541M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.71% |
| 2 | Technology | 23.68% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Shopify
SHOP
$192B
| $153M | 0.46% |
1,044,410
-21,300
| -2% | -$2.62M |
|
|
INBX
52
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $146M | 0.44% |
5,305,866
| – | – |
|
53
Atlassian
TEAM
$43.5B
| $135M | 0.41% |
+523,941
| New | +$123M |
|
|
54
Alphabet (Google) Class A
GOOGL
$4.22T
| $133M | 0.4% |
1,092,740
-7,994,420
| -88% | -$934M |
|
55
Royalty Pharma
RPRX
$27.3B
| $133M | 0.4% |
3,238,654
+1,176,901
| +57% | +$50.1M |
|
56
Snowflake
SNOW
$115B
| $132M | 0.4% |
545,741
-81,416
| -13% | -$18.9M |
|
57
Charles River Laboratories
CRL
$14.1B
| $130M | 0.39% |
351,868
-96,848
| -22% | -$32.3M |
|
58
Acadia Healthcare
ACHC
$2.59B
| $129M | 0.39% |
2,060,125
+408,135
| +25% | +$25.6M |
|
59
Zentalis Pharmaceuticals
ZNTL
$363M
| $128M | 0.39% |
2,399,284
| – | – |
|
|
GTM
60
ZoomInfo Technologies
GTM
$1.16B
| $124M | 0.38% |
+2,381,274
| New | +$112M |
|
|
CTLT
61
DELISTED
CATALENT, INC.
CTLT
| $121M | 0.37% |
1,118,465
+364,085
| +48% | +$39M |
|
|
WBA
62
DELISTED
Walgreens Boots Alliance
WBA
| $114M | 0.35% |
2,168,879
+452,184
| +26% | +$24.3M |
|
|
HZNP
63
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $110M | 0.33% |
1,170,211
-945,446
| -45% | -$87M |
|
64
4D Molecular Therapeutics
FDMT
$875M
| $94.8M | 0.29% |
3,937,914
| – | – |
|
|
KRTX
65
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $93.8M | 0.28% |
822,465
+221,321
| +37% | +$25.9M |
|
66
AdaptHealth
AHCO
$751M
| $84.9M | 0.26% |
+3,096,428
| New | +$88.3M |
|
67
DoorDash
DASH
$96.8B
| $82.7M | 0.25% |
463,778
-146,795
| -24% | -$21.5M |
|
68
Charter Communications
CHTR
$17.9B
| $80.6M | 0.24% |
+111,727
| New | +$75.2M |
|
69
International Flavors & Fragrances
IFF
$21.5B
| $76M | 0.23% |
+508,434
| New | +$73M |
|
70
PVH
PVH
$3.62B
| $68.8M | 0.21% |
639,474
-293,738
| -31% | -$32.3M |
|
71
Peloton Interactive
PTON
$2.37B
| $65.1M | 0.2% |
+524,792
| New | +$55.9M |
|
72
PMV Pharmaceuticals
PMVP
$71.1M
| $61.2M | 0.19% |
1,790,284
-296,000
| -14% | -$9.89M |
|
73
Edgewise Therapeutics
EWTX
$4.8B
| $58.2M | 0.18% |
2,727,249
-625,000
| -19% | -$17.1M |
|
74
Canadian National Railway
CNI
$78.5B
| $56.7M | 0.17% |
+537,655
| New | +$59.3M |
|
|
TRML
75
DELISTED
Tourmaline Bio
TRML
| $48.3M | 0.15% |
+328,962
| New | +$50.4M |
|
Similar funds
Andreas Halvorsen's Q2 2021 Portfolio in Review
As of Q2 2021, Andreas Halvorsen held 117 positions worth $33B, down 1.8% from $33.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Andreas Halvorsen withdrew a net $2.78B in Q2 2021, closing 29 positions and reducing 29 holdings. Its most notable exit was AbCellera Biologics, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
Against the trend, Andreas Halvorsen opened a new position in JD.com worth $658M.
- Andreas Halvorsen's largest Q2 2021 buy was JD.com: 8,241,079 shares worth $658M.
- Andreas Halvorsen added most to Amazon in Q2 2021, an estimated $974M increase.
- Andreas Halvorsen's biggest Q2 2021 reduction was Bank of America, cutting an estimated $989M.
- Andreas Halvorsen fully exited AbCellera Biologics in Q2 2021, selling an estimated $648M.
- Andreas Halvorsen's ten largest holdings make up 37% of its $33B portfolio in Q2 2021.
- Andreas Halvorsen opened 22 new positions and closed 29 in Q2 2021.
- Andreas Halvorsen's portfolio value fell 1.8% quarter-over-quarter to $33B.
Based on Viking Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.